All products / DC7944
LY2090314
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $750 USDRequest a quote → |
| 250 mg | $1,300 USDRequest a quote → |
| 1 g | $2,600 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
LY2090314 is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) with IC50 values of 1.5 nM and 0.9 nM for GSK-3α and GSK-3β, respectively.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC7944 |
|---|---|
| Product name | LY2090314 |
| CAS | 603288-22-8 |
| Molecular formula | C28N6O3FH25 |
| Molecular weight | 512.5349 |
| Purity | >98% |
| SMILES | FC1C([H])=C2C(C3C(N([H])C(C=3C3=C([H])N=C4C([H])=C([H])C([H])=C([H])N34)=O)=O)=C([H])N3C([H])([H])C([H])([H])N(C(N4C([H])([H])C([H])([H])C([H])([H])C([H])([H])C4([H])[H])=O)C([H])([H])C(C=1[H])=C32 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — LY2090314 (DC7944)Source references
[1]. Zamek-Gliszczynski MJ, et al. Pharmacokinetics, metabolism, and excretion of the glycogen synthase kinase-3 inhibitor LY2090314 in rats, dogs, and humans: a case study in rapid clearance by extensive metabolism with low circulating metabolite exposure. Dr [2]. Atkinson JM, et al. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3. PLoS One. 2015 Apr 27;10(4):e0125028.
